Trince Bio

Trince is a spin-off company from Ghent University developing a novel intracellular functional compound delivery technology (LumiPore). One important application is the genetic engineering of immune cells for cancer therapy. Genetic engineering of cells requires specialized technology able to deliver gene-modifying molecules in cells without interfering with the cell’s normal functioning and therapeutic potential.